COO, Customer Operations of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), Walkey Carl, sells 1,800 shares worth $21,996
According to Neoleukin Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 16 07:08 PM, company COO, Customer Operations, Walkey Carl disclosed selling 1,800 shares at a cost of $12.22. At the time of this transaction (Apr 14), this trade was worth $21,996 in total. As of Apr 14, Walkey Carl now owns 1,361,962 shares in total worth about $16,289,065.520000001.
For the last few recent trades made by Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) COO, Customer Operations, Walkey Carl, we have the following information:
- SEC Form 4 filing: Apr 05: Sold 600 shares at the rate of $13.00 per share. Total worth of this trade was $7,800. Total number of shares owned as of Apr 05 were 1,365,562
- SEC Form 4 filing: Mar 22: Sold 600 shares at the rate of $12.00 per share. Total worth of this trade was $7,200. Total number of shares owned as of Mar 22 were 1,369,762
- SEC Form 4 filing: Mar 17: Sold 1,200 shares at the rate of $11.36 per share. Total worth of this trade was $13,632. Total number of shares owned as of Mar 17 were 1,370,362
Posted by
George Daniels
on Saturday April 17 2021, 3:03 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
